441 filings
Page 13 of 23
8-K
23en1do
10 May 17
Tim Morris; AcelRx Pharmaceuticals, Inc.; CFO and Head of Business Development
12:00am
DEFA14A
cpgtv
28 Apr 17
Additional proxy soliciting materials
12:00am
CT ORDER
7160zmkikc9u9quydl
17 Mar 17
Confidential treatment order
12:00am
CT ORDER
n2pudaq7updpu12hof9
17 Mar 17
Confidential treatment order
12:00am
8-K
rzjxul6t1 mx1706gi
10 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
62p8jam
7 Mar 17
Tim Morris; AcelRx Pharmaceuticals, Inc.; CFO and Head of Business Development
12:00am
S-8
cvqym f20jd
7 Mar 17
Registration of securities for employees
12:00am
8-K
t8rc 7hgk0d7g1lbe
16 Feb 17
Departure of Directors or Certain Officers
12:00am
8-K
s8t6lilv0a
9 Feb 17
Departure of Directors or Certain Officers
12:00am
CT ORDER
md16 sc8ia9fb
27 Jan 17
Confidential treatment order
12:00am
8-K
lu3zmf6kti2ouk7v
9 Jan 17
Results of Operations and Financial Condition
12:00am
8-K
ytt1bsfrxc8
13 Dec 16
AcelRx Pharmaceuticals Submits New Drug Application for ARX-04 for the Treatment of Moderate-To-Severe Acute Pain
12:00am
8-K
obue6
1 Dec 16
Regulation FD Disclosure
12:00am
8-K
ijt9a sofwy
3 Nov 16
Tim Morris; AcelRx Pharmaceuticals, Inc.; CFO and Head of Business Development
12:00am
8-K
zci7i 5g5aga
3 Oct 16
Entry into a Material Definitive Agreement
12:00am
8-K
60xec0 x5xc5
27 Sep 16
Regulation FD Disclosure
12:00am